| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/20/2010 | CA2743677A1 Degradable supports for tide synthesis |
| 05/19/2010 | EP2186524A1 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis |
| 05/19/2010 | EP2185575A1 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 05/19/2010 | EP2184987A1 Bi-dentate compounds as kinase inhibitors |
| 05/19/2010 | CN101711280A TEM8 peptides and vaccines comprising the same |
| 05/19/2010 | CN101709078A immune-modulating peptide |
| 05/19/2010 | CN101113457B Method for synthesizing arginine-enriched polypeptide-gold nano particle cell transmission carrier |
| 05/18/2010 | US7718777 MHC-peptide complex binding ligands |
| 05/18/2010 | US7718772 Canine thymic stromal lymphopoietin protein and uses thereof |
| 05/18/2010 | US7718768 Biologically active peptide PTTKTYFPHF |
| 05/18/2010 | US7718767 Administering for example 3-[(R)-2-(N,N-dimethylamino)ethylthio-Sarcosine]-4-(gamma hydroxymethylleucine)cyclosporin, or salts or hydrates thereof; improved nephrotoxicity and/or hepatotoxicity |
| 05/18/2010 | US7718764 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/18/2010 | US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ |
| 05/18/2010 | US7718611 Cyclic nonapeptide amides |
| 05/18/2010 | US7718610 Retrocyclins: antiviral and antimicrobial peptides |
| 05/18/2010 | US7718598 preparing cyclic peptides by cyclization of a peptide molecule; linking a cyclic aromatic auxiliary compound 5-nitrosalicylaldehyde to a primary amine nitrogen atom of a peptide; solid phase synthesis; improve in both yields and purity of products |
| 05/18/2010 | US7718376 Identification and isolation of somatic stem cells and uses thereof |
| 05/18/2010 | CA2402193C Novel lhrh-antagonists, production and use thereof as medicament |
| 05/15/2010 | CA2739663A1 Polypeptides that bind trail-r1 and trail-r2 |
| 05/14/2010 | WO2010054326A2 C-terminal fragments of glucagon-like peptide-1 (glp-1) |
| 05/14/2010 | WO2010054316A2 Endothelium mimicking nanomatrix |
| 05/14/2010 | WO2010054108A2 Cas6 polypeptides and methods of use |
| 05/14/2010 | WO2010053763A1 Tumor-targeting peptides and uses thereof |
| 05/14/2010 | WO2010052559A1 Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| 05/14/2010 | WO2010011999A3 Methods and compositions for eliciting an amyloid-selective immune response |
| 05/14/2010 | WO2010003053A3 Hsv-2 peptides for stimulation of cytotoxic t lymphocytes |
| 05/14/2010 | WO2009126349A3 Methods and compositions related to internalizing rgd peptides |
| 05/14/2010 | CA2742782A1 Endothelium mimicking nanomatrix |
| 05/14/2010 | CA2741829A1 Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| 05/13/2010 | US20100121039 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 05/13/2010 | US20100121027 Cyclic Peptide Compositions for Treatment of Sexual Dysfunction |
| 05/13/2010 | US20100120697 Tumor Activated Prodrugs |
| 05/13/2010 | US20100120696 Peptides Having Activities of Epidermal Growth Factor and Its Uses |
| 05/13/2010 | US20100120695 Polypeptides that bind membrane proteins |
| 05/13/2010 | US20100120694 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 05/13/2010 | US20100120688 ErbB Interface Peptidomimetics And Methods Of Use Thereof |
| 05/13/2010 | US20100120679 Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy |
| 05/13/2010 | US20100120678 Novel inhibitors of the egfr kinase targeting the asymmetric activating dimer interface |
| 05/13/2010 | US20100120672 cyclic peptide compounds |
| 05/13/2010 | US20100120670 Cyclised alpha-conotoxin peptides |
| 05/13/2010 | US20100120039 Methods and compositions in breast cancer therapy resistance |
| 05/13/2010 | US20100119573 Endothelium mimicking nanomatrix |
| 05/13/2010 | US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2010 | US20100119536 Naturally Processed Measles Virus Peptides From Class II HLA Molecules |
| 05/13/2010 | US20100119533 Polynucleotides and Polypeptides Identified by IVIAT Screening and Methods of Use |
| 05/13/2010 | US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus |
| 05/13/2010 | US20100119444 Tumor-Targeting Peptides and Uses Thereof |
| 05/12/2010 | EP2184291A1 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 05/12/2010 | EP2184290A1 Method for producing peptide |
| 05/12/2010 | EP2183361A1 Novel immunotherapy against neuronal and brain tumors |
| 05/12/2010 | EP2183272A2 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment |
| 05/12/2010 | EP2183271A1 Caspofungin free of caspofungin impurity a |
| 05/12/2010 | EP2183270A1 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 05/12/2010 | EP1996633B1 Molecular imprintings for recognition in aqueous media, methods for preparing same and uses thereof |
| 05/12/2010 | CN1972960B Processes for preparing eptifibatide |
| 05/12/2010 | CN1798764B Peptide inhibitors of toxins derived from LL-37 |
| 05/12/2010 | CN101704878A Polypeptide derivatives for generating stable micro-molecular hydrogel |
| 05/12/2010 | CN101195653B solid-liquid synthesizing method for leuprorelin |
| 05/11/2010 | US7714106 Neuropeptides and their use for pest control |
| 05/11/2010 | US7714105 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| 05/11/2010 | US7713931 Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/11/2010 | US7713714 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof |
| 05/11/2010 | CA2205237C Pesticidal composition comprising cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin |
| 05/06/2010 | WO2010051274A2 Fibronectin type iii domain based scaffold compositions, methods and uses |
| 05/06/2010 | WO2010050181A1 Vaccine for preventing onset and recurrence of liver cancer induced by hepatitis c virus |
| 05/06/2010 | WO2010021849A3 Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae |
| 05/06/2010 | WO2010017653A8 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof |
| 05/06/2010 | US20100113470 Bcr-abl variants |
| 05/06/2010 | US20100113369 Means for preventing and treating cellular death and their biological applications |
| 05/06/2010 | US20100113368 Cholesterol lowering protein hydrolysates |
| 05/06/2010 | US20100113367 Peptide-cytotoxic conjugates |
| 05/06/2010 | US20100113366 Use of proline-rich peptide derived from hypothalamus for the manufacture of a medicament for the treatment and/or prophylaxis of cattle leucosis |
| 05/06/2010 | US20100113342 Antimicrobial kinocidin compositions and methods of use |
| 05/06/2010 | US20100112635 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 05/06/2010 | US20100112582 Gene encoding labyrinthin, a marker for cancer |
| 05/06/2010 | US20100112571 Compositions and methods for detecting mutations in jak2 nucleic acid |
| 05/06/2010 | US20100112089 Peptide compound and use thereof |
| 05/06/2010 | US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 05/06/2010 | US20100111988 Small peptide for anti-angiogenesis and use thereof |
| 05/06/2010 | US20100111980 Binding partners of antibodies specific for dendritic cell antigens |
| 05/06/2010 | US20100111974 Treatment of Cachexia |
| 05/06/2010 | US20100111949 Methods and compositions for the treatment of proliferative diseases |
| 05/06/2010 | US20100111871 Photoacoustic probes and methods of imaging |
| 05/06/2010 | US20100111866 Receptor and Antigen Targeted Prodrug |
| 05/06/2010 | US20100111838 Brain-localizing polypeptides comprising a multivalent binding moiety and improved metabolic stability |
| 05/05/2010 | EP2182003A1 Peptide capable of binding to immunoglobulin |
| 05/05/2010 | EP2181731A1 Organic compounds with biological effect as thrombin inhibitor and use of same |
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181595A1 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 05/05/2010 | EP2181119A1 Isoelectric point markers |
| 05/05/2010 | EP1871785B1 Compositions and methods for fusion protein separation |
| 05/05/2010 | EP1790655B1 Biologically active peptides |
| 05/05/2010 | EP1567545B1 Peptides and their use in the treatment of central nervous system damage |
| 05/05/2010 | EP0703783B1 Methods of making immunogenic hla-a2.1 binding peptides |
| 05/05/2010 | CN1976947B Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 05/05/2010 | CN1902217B Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 05/05/2010 | CN1446261B Modified cytokines for use in cancer therapy |
| 05/04/2010 | US7709609 Tumor suppressor gene, p47ING3 |
| 05/04/2010 | US7709443 For treatment of human melanoma, pancreatic, breast, prostate cancer cells |
| 05/04/2010 | CA2318494C Angiotensin converting enzyme inhibitor |